SHELLY SCHNEIDER: Open Payments
NPI 1124003017 · WOODBURY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,379 in 161 payments from 18 companies in 2025. Trend: 2023 $3,326 · 2024 $4,007 · 2025 $3,379
Food & beverage: $3,279Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 23 | $683 |
| UCB, Inc. | 13 | $511 |
| ABBVIE INC. | 27 | $393 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $274 |
| LEO Pharma Inc. | 26 | $270 |
| Lilly USA, LLC | 7 | $227 |
| Incyte Corporation | 6 | $217 |
| E.R. Squibb & Sons, L.L.C. | 13 | $172 |
| Journey Medical Corporation | 1 | $125 |
| Novartis Pharmaceuticals Corporation | 7 | $120 |
Products named: TREMFYA, Bimzelx, SKYRIZI, ADBRY, OPZELURA, Sotyktu, ILUMYA, EBGLYSS.
Industry payments across NJ — which companies pay providers there.
